Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome

Previous histochemical studies in the demyelinating form of Guillain-Barré syndrome (GBS), acute inflammatory demyelinating polyneuropathy (AIDP), have shown complement deposition on the surface of Schwann cells, and therefore unknown epitopes would be present on the outer surface of Schwann cells....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurology Ročník 83; číslo 2; s. 113
Hlavní autoři: Sawai, Setsu, Satoh, Mamoru, Mori, Masahiro, Misawa, Sonoko, Sogawa, Kazuyuki, Kazami, Takahiro, Ishibashi, Masumi, Beppu, Minako, Shibuya, Kazumoto, Ishige, Takayuki, Sekiguchi, Yukari, Noda, Kenta, Sato, Kenichi, Matsushita, Kazuyuki, Kodera, Yoshio, Nomura, Fumio, Kuwabara, Satoshi
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 08.07.2014
Témata:
ISSN:1526-632X, 1526-632X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Previous histochemical studies in the demyelinating form of Guillain-Barré syndrome (GBS), acute inflammatory demyelinating polyneuropathy (AIDP), have shown complement deposition on the surface of Schwann cells, and therefore unknown epitopes would be present on the outer surface of Schwann cells. We used a proteomic-based approach to search for the target molecules of AIDP in the extracted proteins from schwannoma cells. Sera were obtained from 40 patients with GBS, 31 controls with inflammatory disease, and 46 normal controls. We found that patients with AIDP after cytomegalovirus (CMV) infection have serum autoantibodies against membrane-organizing extension spike protein (moesin), which is expressed in the Schwann cell processes at the nodes of Ranvier and is crucial for myelination. Of the 40 patients with GBS, 6 had recent CMV infection and 5 of them (83%) had high levels of serum immunoglobulin G antibodies against moesin. The anti-moesin antibodies were found in none of the control subjects with disease including 5 with CMV infection but no neuropathy, and only 2 (4%) of the 46 normal control subjects. Immunocytochemistry showed that moesin was stained at the distal tips of schwannoma cells by sera from the patients with CMV-related AIDP but not by sera from controls. Moesin is a possible immunologic target molecule of pathogenic autoantibodies in patients with CMV-related AIDP. This study provides Class II evidence that levels of serum anti-moesin antibodies accurately distinguishes CMV-related AIDP from non-CMV-related AIDP (sensitivity 83%, specificity 93%).
AbstractList Previous histochemical studies in the demyelinating form of Guillain-Barré syndrome (GBS), acute inflammatory demyelinating polyneuropathy (AIDP), have shown complement deposition on the surface of Schwann cells, and therefore unknown epitopes would be present on the outer surface of Schwann cells.OBJECTIVEPrevious histochemical studies in the demyelinating form of Guillain-Barré syndrome (GBS), acute inflammatory demyelinating polyneuropathy (AIDP), have shown complement deposition on the surface of Schwann cells, and therefore unknown epitopes would be present on the outer surface of Schwann cells.We used a proteomic-based approach to search for the target molecules of AIDP in the extracted proteins from schwannoma cells. Sera were obtained from 40 patients with GBS, 31 controls with inflammatory disease, and 46 normal controls.METHODSWe used a proteomic-based approach to search for the target molecules of AIDP in the extracted proteins from schwannoma cells. Sera were obtained from 40 patients with GBS, 31 controls with inflammatory disease, and 46 normal controls.We found that patients with AIDP after cytomegalovirus (CMV) infection have serum autoantibodies against membrane-organizing extension spike protein (moesin), which is expressed in the Schwann cell processes at the nodes of Ranvier and is crucial for myelination. Of the 40 patients with GBS, 6 had recent CMV infection and 5 of them (83%) had high levels of serum immunoglobulin G antibodies against moesin. The anti-moesin antibodies were found in none of the control subjects with disease including 5 with CMV infection but no neuropathy, and only 2 (4%) of the 46 normal control subjects. Immunocytochemistry showed that moesin was stained at the distal tips of schwannoma cells by sera from the patients with CMV-related AIDP but not by sera from controls.RESULTSWe found that patients with AIDP after cytomegalovirus (CMV) infection have serum autoantibodies against membrane-organizing extension spike protein (moesin), which is expressed in the Schwann cell processes at the nodes of Ranvier and is crucial for myelination. Of the 40 patients with GBS, 6 had recent CMV infection and 5 of them (83%) had high levels of serum immunoglobulin G antibodies against moesin. The anti-moesin antibodies were found in none of the control subjects with disease including 5 with CMV infection but no neuropathy, and only 2 (4%) of the 46 normal control subjects. Immunocytochemistry showed that moesin was stained at the distal tips of schwannoma cells by sera from the patients with CMV-related AIDP but not by sera from controls.Moesin is a possible immunologic target molecule of pathogenic autoantibodies in patients with CMV-related AIDP.CONCLUSIONMoesin is a possible immunologic target molecule of pathogenic autoantibodies in patients with CMV-related AIDP.This study provides Class II evidence that levels of serum anti-moesin antibodies accurately distinguishes CMV-related AIDP from non-CMV-related AIDP (sensitivity 83%, specificity 93%).CLASSIFICATION OF EVIDENCEThis study provides Class II evidence that levels of serum anti-moesin antibodies accurately distinguishes CMV-related AIDP from non-CMV-related AIDP (sensitivity 83%, specificity 93%).
Previous histochemical studies in the demyelinating form of Guillain-Barré syndrome (GBS), acute inflammatory demyelinating polyneuropathy (AIDP), have shown complement deposition on the surface of Schwann cells, and therefore unknown epitopes would be present on the outer surface of Schwann cells. We used a proteomic-based approach to search for the target molecules of AIDP in the extracted proteins from schwannoma cells. Sera were obtained from 40 patients with GBS, 31 controls with inflammatory disease, and 46 normal controls. We found that patients with AIDP after cytomegalovirus (CMV) infection have serum autoantibodies against membrane-organizing extension spike protein (moesin), which is expressed in the Schwann cell processes at the nodes of Ranvier and is crucial for myelination. Of the 40 patients with GBS, 6 had recent CMV infection and 5 of them (83%) had high levels of serum immunoglobulin G antibodies against moesin. The anti-moesin antibodies were found in none of the control subjects with disease including 5 with CMV infection but no neuropathy, and only 2 (4%) of the 46 normal control subjects. Immunocytochemistry showed that moesin was stained at the distal tips of schwannoma cells by sera from the patients with CMV-related AIDP but not by sera from controls. Moesin is a possible immunologic target molecule of pathogenic autoantibodies in patients with CMV-related AIDP. This study provides Class II evidence that levels of serum anti-moesin antibodies accurately distinguishes CMV-related AIDP from non-CMV-related AIDP (sensitivity 83%, specificity 93%).
Author Shibuya, Kazumoto
Sawai, Setsu
Matsushita, Kazuyuki
Sekiguchi, Yukari
Ishibashi, Masumi
Sato, Kenichi
Misawa, Sonoko
Kodera, Yoshio
Kuwabara, Satoshi
Nomura, Fumio
Beppu, Minako
Satoh, Mamoru
Mori, Masahiro
Sogawa, Kazuyuki
Kazami, Takahiro
Ishige, Takayuki
Noda, Kenta
Author_xml – sequence: 1
  givenname: Setsu
  surname: Sawai
  fullname: Sawai, Setsu
  email: ssawai@faculty.chiba-u.jp
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan. ssawai@faculty.chiba-u.jp
– sequence: 2
  givenname: Mamoru
  surname: Satoh
  fullname: Satoh, Mamoru
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 3
  givenname: Masahiro
  surname: Mori
  fullname: Mori, Masahiro
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 4
  givenname: Sonoko
  surname: Misawa
  fullname: Misawa, Sonoko
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 5
  givenname: Kazuyuki
  surname: Sogawa
  fullname: Sogawa, Kazuyuki
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 6
  givenname: Takahiro
  surname: Kazami
  fullname: Kazami, Takahiro
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 7
  givenname: Masumi
  surname: Ishibashi
  fullname: Ishibashi, Masumi
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 8
  givenname: Minako
  surname: Beppu
  fullname: Beppu, Minako
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 9
  givenname: Kazumoto
  surname: Shibuya
  fullname: Shibuya, Kazumoto
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 10
  givenname: Takayuki
  surname: Ishige
  fullname: Ishige, Takayuki
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 11
  givenname: Yukari
  surname: Sekiguchi
  fullname: Sekiguchi, Yukari
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 12
  givenname: Kenta
  surname: Noda
  fullname: Noda, Kenta
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 13
  givenname: Kenichi
  surname: Sato
  fullname: Sato, Kenichi
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 14
  givenname: Kazuyuki
  surname: Matsushita
  fullname: Matsushita, Kazuyuki
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 15
  givenname: Yoshio
  surname: Kodera
  fullname: Kodera, Yoshio
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 16
  givenname: Fumio
  surname: Nomura
  fullname: Nomura, Fumio
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
– sequence: 17
  givenname: Satoshi
  surname: Kuwabara
  fullname: Kuwabara, Satoshi
  organization: From the Departments of Molecular Diagnosis (S.S., M.S., K. Sogawa, T.K., M.I., M.B., T.I., K.N., K. Sato, K.M., F.N.) and Neurology (M.M., S.M., M.B., K. Shibuya, Y.S., S.K.), Graduate School of Medicine, Chiba University; and Department of Physics (Y.K.), School of Science, Kitasato University, Kanagawa, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24920858$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1KxDAUhYOMOD_6BiJZuumYpPlpljqMozDqRlFXJW1vhkjbjEkrzCP5HL6YBUeYs7n3XD4uhzNFo9a3gNA5JXPKKLt6fVzPyaGElEdoQgWTiUzZ2-hgH6NpjB-EDAelT9CYcc1IJrIJen_wEF2LXcQGb32MrqgBdyZsoMONr6HsB299wOWu8w1sTO2_XOhjEqA2HVR41bu6Nq5NbkwIP9847toqDOQpOramjnC2nzP0crt8Xtwl66fV_eJ6nZQ8EzLRxqqyLC0IVnAiNFMctKGUEmGpLICmlVJEU2KE1SRNDQclhuhZobSVFNgMXf793Qb_2UPs8sbFEoZMLfg-5lTwVGuuiR7Qiz3aFw1U-Ta4xoRd_l8H-wWC_WWA
CitedBy_id crossref_primary_10_1111_cen3_12184
crossref_primary_10_1212_WNL_0000000000000581
crossref_primary_10_1038_nrneurol_2015_192
crossref_primary_10_1016_j_autrev_2016_03_020
crossref_primary_10_3390_jcm13195721
crossref_primary_10_1212_WNL_0000000000001090
crossref_primary_10_1007_s13311_021_01117_3
crossref_primary_10_1016_j_mehy_2020_110342
crossref_primary_10_1016_j_autrev_2014_08_005
crossref_primary_10_1111_cen3_12339
crossref_primary_10_1016_j_jaut_2020_102571
crossref_primary_10_1016_S0140_6736_16_00339_1
crossref_primary_10_1007_s00705_021_04959_6
crossref_primary_10_1007_s15010_015_0819_1
crossref_primary_10_1111_cen3_12457
crossref_primary_10_3390_ijms23148038
crossref_primary_10_1111_tid_12516
crossref_primary_10_1007_s00415_019_09308_x
crossref_primary_10_7759_cureus_35889
crossref_primary_10_1212_WNL_0000000000004773
crossref_primary_10_1111_jns_12568
crossref_primary_10_1007_s00415_015_7806_4
crossref_primary_10_3233_JND_150078
crossref_primary_10_1016_j_humimm_2014_09_010
crossref_primary_10_1038_cmi_2017_142
crossref_primary_10_1136_jnnp_2014_309697
crossref_primary_10_1016_j_jneuroim_2015_07_012
crossref_primary_10_1136_jnnp_2019_322479
crossref_primary_10_1038_nrneurol_2014_260
crossref_primary_10_1016_S0140_6736_21_00517_1
crossref_primary_10_3390_cells10040844
crossref_primary_10_1111_cen3_12645
crossref_primary_10_1007_s12192_020_01145_6
crossref_primary_10_1038_s41572_018_0027_2
crossref_primary_10_3390_diagnostics11081339
ContentType Journal Article
Copyright 2014 American Academy of Neurology.
Copyright_xml – notice: 2014 American Academy of Neurology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1212/WNL.0000000000000566
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1526-632X
ExternalDocumentID 24920858
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.XZ
.Z2
01R
0R~
123
1J1
29N
354
3PY
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
77Y
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAWTL
AAXQO
AAYEP
ABBLC
ABIVO
ABJNI
ABOCM
ABPXF
ABVCZ
ABXYN
ABZZY
ACCJW
ACDDN
ACGFS
ACILI
ACLDA
ACOAL
ACWRI
ACXJB
ACZKN
ADGGA
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFNMH
AFUWQ
AGINI
AHOMT
AHQNM
AHQVU
AHVBC
AIJEX
AJCLO
AKCTQ
AKULP
AKWKN
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AMNEI
AOHHW
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
E.X
EBS
ECM
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GQDEL
HZ~
IKYAY
IN~
JF7
KD2
KMI
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHYEH
OL1
OLB
OLH
OLU
OLV
OLY
OLZ
OPX
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RLZ
RXW
SJN
TEORI
V2I
VVN
W3M
WH7
WOQ
WOW
XSW
XXN
XYM
XYN
YBU
YFH
~9M
7X8
ADKSD
ADSXY
ID FETCH-LOGICAL-c4856-9af7cccfe52b4059274e9a11105f16be13d770910a5f9033a4e758588b79f61e2
IEDL.DBID 7X8
ISICitedReferencesCount 39
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000340103400036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1526-632X
IngestDate Mon Sep 08 04:29:17 EDT 2025
Mon Jul 21 05:56:55 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License 2014 American Academy of Neurology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4856-9af7cccfe52b4059274e9a11105f16be13d770910a5f9033a4e758588b79f61e2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24920858
PQID 1543994909
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1543994909
pubmed_primary_24920858
PublicationCentury 2000
PublicationDate 2014-July-8
PublicationDateYYYYMMDD 2014-07-08
PublicationDate_xml – month: 07
  year: 2014
  text: 2014-July-8
  day: 08
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurology
PublicationTitleAlternate Neurology
PublicationYear 2014
References 24920859 - Neurology. 2014 Jul 8;83(2):106-8
25488994 - Neurology. 2014 Dec 9;83(24):2314
25632420 - Neurology. 2014 Dec 9;83(24):2314; discussion 2314-5
References_xml – reference: 24920859 - Neurology. 2014 Jul 8;83(2):106-8
– reference: 25488994 - Neurology. 2014 Dec 9;83(24):2314
– reference: 25632420 - Neurology. 2014 Dec 9;83(24):2314; discussion 2314-5
SSID ssj0015279
Score 2.3631258
Snippet Previous histochemical studies in the demyelinating form of Guillain-Barré syndrome (GBS), acute inflammatory demyelinating polyneuropathy (AIDP), have shown...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 113
SubjectTerms Antigens, Viral - analysis
Blotting, Western
Cell Line, Tumor
Cytomegalovirus Infections - complications
Cytomegalovirus Infections - drug therapy
Electrodiagnosis
Electrophoresis, Agar Gel
Guillain-Barre Syndrome - drug therapy
Guillain-Barre Syndrome - etiology
Humans
Immunoglobulin G - analysis
Immunoglobulin M - analysis
Immunohistochemistry
Microfilament Proteins - drug effects
Neurilemmoma - pathology
Proteomics
Recombinant Proteins - analysis
Title Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/24920858
https://www.proquest.com/docview/1543994909
Volume 83
WOSCitedRecordID wos000340103400036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAIsSFfSmbjMTVarM4sU8IEIUDrXoAUU6VY4-lSDQpTVuJT-I7-DHGSapeOCCRQ3KKFE3GM2884_cIuVI8SfBXGwaYW1gojWQyFBFLZFsrsMZLPFWKTcS9nhgMZL_ecCvqscpFTCwDtcm12yNvYarHXBrKtrwefzCnGuW6q7WExippBAhlnFfHg2UXgfsl1x4-IxYF_qA-OofRuvXae6qoCxcXr3kSfwWZZbLpbP_3M3fIVg0z6U3lF7tkBbI9stGtG-n75K2bQ5FmNC2oouPcLYx3oNVYOB1VkrlAEdBS_TnNR4B5JJ-nk1nBysMvYOjDzOkVpRm7VZPJ9xddUB8ckJfO_fPdI6tVFpgOBY-YVDbWWlvgfoLoTWKZClJhCGxz60UJeIGJY4cqFLeyHQQqBFdjCJHE0kYe-IdkLcszOCbU48LXPhirI4GVlEpMIEMusGKxRsc2apLLhdGG6MWuNaEyyGfFcGm2JjmqLD8cV3QbQ8dpiMBQnPzh7VOyiYgmLOdpxRlpWFzDcE7W9XyaFpOL0j3w3ut3fwCezMUP
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Moesin+is+a+possible+target+molecule+for+cytomegalovirus-related+Guillain-Barr%C3%A9+syndrome&rft.jtitle=Neurology&rft.au=Sawai%2C+Setsu&rft.au=Satoh%2C+Mamoru&rft.au=Mori%2C+Masahiro&rft.au=Misawa%2C+Sonoko&rft.date=2014-07-08&rft.issn=1526-632X&rft.eissn=1526-632X&rft.volume=83&rft.issue=2&rft.spage=113&rft_id=info:doi/10.1212%2FWNL.0000000000000566&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1526-632X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1526-632X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1526-632X&client=summon